EA200801833A1 - Способы получения кристаллических форм дулоксетина гидрохлорида - Google Patents
Способы получения кристаллических форм дулоксетина гидрохлоридаInfo
- Publication number
- EA200801833A1 EA200801833A1 EA200801833A EA200801833A EA200801833A1 EA 200801833 A1 EA200801833 A1 EA 200801833A1 EA 200801833 A EA200801833 A EA 200801833A EA 200801833 A EA200801833 A EA 200801833A EA 200801833 A1 EA200801833 A1 EA 200801833A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- methods
- hydrochloride
- duloxethine
- crystalline forms
- obtaining crystalline
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Настоящее изобретение также относится к способам получения формы А и формы Т, которые включают растворение дулоксетина гидрохлорида в конкретных растворителях и охлаждение раствора с получением кристаллов, которые высушивают.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06003244A EP1820800A1 (en) | 2006-02-17 | 2006-02-17 | Crystalline forms of duloxetine hydrochloride and processes for their preparation |
PCT/EP2007/001380 WO2007093439A1 (en) | 2006-02-17 | 2007-02-16 | Processes for the preparation of crystalline forms of duloxetine hydrochloride |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200801833A1 true EA200801833A1 (ru) | 2008-12-30 |
Family
ID=36754582
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200801833A EA200801833A1 (ru) | 2006-02-17 | 2007-02-16 | Способы получения кристаллических форм дулоксетина гидрохлорида |
Country Status (3)
Country | Link |
---|---|
EP (3) | EP1820800A1 (ru) |
EA (1) | EA200801833A1 (ru) |
WO (1) | WO2007093439A1 (ru) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007067581A1 (en) | 2005-12-05 | 2007-06-14 | Teva Pharmaceutical Industries Ltd. | 2-(n-methyl-propanamine)-3-(2-naphthol) thiophene, an impurity of duloxetine hydrochloride |
CN101448815A (zh) * | 2006-05-23 | 2009-06-03 | 特瓦制药工业有限公司 | 度洛西汀hci多晶型物 |
GB0612506D0 (en) | 2006-06-23 | 2006-08-02 | Arrow Int Ltd | Crystalline duloxetine hydrochloride |
GB0612508D0 (en) * | 2006-06-23 | 2006-08-02 | Arrow Int Ltd | Crystalline duloxetine hydrochloride |
GB0612509D0 (en) * | 2006-06-23 | 2006-08-02 | Arrow Int Ltd | Crystalline duloxetine hydrochloride |
WO2008107911A2 (en) | 2007-03-05 | 2008-09-12 | Lupin Limited | Novel process for preparation of duloxetine hydrochloride |
US9358213B2 (en) * | 2007-04-20 | 2016-06-07 | Wockhardt Limited | Pharmaceutical compositions of duloxetine |
EP2182929A2 (en) * | 2007-07-13 | 2010-05-12 | Synthon B.V. | Duloxetine formulations |
CA2712282A1 (en) * | 2008-01-25 | 2009-07-30 | Alphapharm Pty Ltd | Delayed release pharmaceutical composition of duloxetine |
EA201001871A1 (ru) * | 2008-06-13 | 2011-08-30 | Крка, Д.Д. Ново Место | Гастрорезистентные пероральные фармацевтические композиции, содержащие дулоксетин или его фармацевтически приемлемые производные |
EP2133072A1 (en) | 2008-06-13 | 2009-12-16 | KRKA, D.D., Novo Mesto | Gastro-resistant pharmaceutical oral compositions comprising duloxetine or its pharmaceutically acceptable derivatives |
CZ304602B6 (cs) * | 2009-09-02 | 2014-07-30 | Zentiva, K. S. | Způsob krystalizace hydrochloridu (S)-N-methyl-3-(1-naftyloxy)-3-(2-thienyl)propylaminu (hydrochloridu duloxetinu) |
ES2601841T3 (es) * | 2010-05-25 | 2017-02-16 | Hetero Research Foundation | Composición farmacéutica oral de duloxetina |
CN103626735A (zh) * | 2012-08-28 | 2014-03-12 | 石药集团中奇制药技术(石家庄)有限公司 | 一种盐酸度洛西汀晶型及其制备方法 |
KR102242670B1 (ko) * | 2014-01-09 | 2021-04-20 | 일동제약(주) | 둘록세틴이 함유된 안정한 다중코팅 정제 조성물 |
CN113603673A (zh) * | 2020-11-16 | 2021-11-05 | 上海中西三维药业有限公司 | 一种盐酸度洛西汀的晶型、其制备方法及其应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4956388A (en) | 1986-12-22 | 1990-09-11 | Eli Lilly And Company | 3-aryloxy-3-substituted propanamines |
US5362886A (en) * | 1993-10-12 | 1994-11-08 | Eli Lilly And Company | Asymmetric synthesis |
US5508276A (en) * | 1994-07-18 | 1996-04-16 | Eli Lilly And Company | Duloxetine enteric pellets |
AU2003263585A1 (en) | 2003-08-25 | 2005-03-10 | Hetero Drugs Limited | Amorphous duloxetine hydrochloride |
US20070141150A1 (en) | 2003-12-30 | 2007-06-21 | Raghupathi Kandarapu | Pharmaceutical composition |
GB0410470D0 (en) * | 2004-05-11 | 2004-06-16 | Cipla Ltd | Pharmaceutical compound and polymorphs thereof |
-
2006
- 2006-02-17 EP EP06003244A patent/EP1820800A1/en not_active Withdrawn
-
2007
- 2007-02-16 WO PCT/EP2007/001380 patent/WO2007093439A1/en active Application Filing
- 2007-02-16 EP EP10186667A patent/EP2308864A1/en not_active Withdrawn
- 2007-02-16 EP EP07703509A patent/EP1984346A1/en not_active Withdrawn
- 2007-02-16 EA EA200801833A patent/EA200801833A1/ru unknown
Also Published As
Publication number | Publication date |
---|---|
EP1820800A1 (en) | 2007-08-22 |
EP1984346A1 (en) | 2008-10-29 |
WO2007093439A1 (en) | 2007-08-23 |
EP2308864A1 (en) | 2011-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200801833A1 (ru) | Способы получения кристаллических форм дулоксетина гидрохлорида | |
EA200900793A1 (ru) | Способ получения эзетимиба и его производных | |
EA201200669A1 (ru) | ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα | |
EA200800760A1 (ru) | ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα | |
EA201070186A1 (ru) | Способы и соединения, предназначенные для получения ингибиторов котранспортера натрий-глюкозы 2 типа | |
ATE491700T1 (de) | KRISTALLINE FORMEN VON 1-CHLORO-4-(ß-D- | |
EA201171200A1 (ru) | Полиморфы элтромбопага и солей элтромбопага, а также способы их получения | |
EA201000883A1 (ru) | Производные индолинона и способ их получения | |
EA201200741A1 (ru) | Способ получения этексилата дабигатрана | |
DK1720571T3 (da) | Fremgangsmåde til behandling af hæmolytisk sygdom | |
BRPI0820689A2 (pt) | processo de produção de um derivado de indolinona | |
EA201000950A1 (ru) | Азолилметилоксираны, их применение, а также содержащие их средства | |
ATE504556T1 (de) | Herstellung von natriumdiformiat | |
NO20053676D0 (no) | Crystallisation Process | |
NO20053687D0 (no) | Crystallisation Process. | |
EA201270535A1 (ru) | Пуриновые производные, применимые в качестве ингибиторов hsp90 | |
BRPI0911549A2 (pt) | processo de expansão de nitrogênio duplo | |
EA201070424A1 (ru) | Хиназолиндионовые производные, их получение и их применения в терапии | |
EA201071120A1 (ru) | Способ получения гетероарилбензопроизводных сульфаматов и кристаллической формы n-((2s)-6-хлор-2,3-дигидро-l,4-бензодиоксин-2-ил)метилсульфамида | |
EA201070228A1 (ru) | Тразодон и гидрохлорид тразодона в очищенной форме | |
EA200801893A1 (ru) | Производные тетрагидронафталина, способ их получения и их применение в качестве ингибиторов воспаления | |
ATE512132T1 (de) | Hydrochloridsalz von 5-ä3-(3- hydroxyphenoxy)azetidin-1-ylü-5-methyl-2,2- diphenylhexanamid | |
EA201792068A3 (ru) | Способ получения органических соединений | |
EA200700807A1 (ru) | Новые циклические и ациклические пропеноны для лечения заболеваний цнс | |
EA201001870A1 (ru) | Новые кристаллические формы рабепразола натрия |